/
/
/

Gufic Biosciences Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
₹261 Cr₹252 Cr₹231 Cr₹237 Cr₹224 Cr₹205 Cr₹208 Cr₹204 Cr₹203 Cr₹195 Cr₹202 Cr₹215 Cr
₹46 L-₹1 Cr₹79 L₹2 Cr₹93 L₹39 L₹2 Cr₹11 L₹1 Cr₹88 L₹42 L₹33 L
₹261 Cr₹251 Cr₹232 Cr₹239 Cr₹225 Cr₹205 Cr₹210 Cr₹204 Cr₹204 Cr₹196 Cr₹202 Cr₹215 Cr
₹222 Cr₹212 Cr₹206 Cr₹207 Cr₹198 Cr₹186 Cr₹178 Cr₹170 Cr₹171 Cr₹165 Cr₹169 Cr₹180 Cr
₹47 Cr₹46 Cr₹34 Cr₹40 Cr₹34 Cr₹27 Cr₹36 Cr₹39 Cr₹37 Cr₹35 Cr₹37 Cr₹40 Cr
₹9 Cr₹9 Cr₹8 Cr₹10 Cr₹9 Cr₹8 Cr₹5 Cr₹5 Cr₹5 Cr₹4 Cr₹3 Cr₹4 Cr
₹30 Cr₹29 Cr₹18 Cr₹23 Cr₹17 Cr₹11 Cr₹26 Cr₹29 Cr₹28 Cr₹27 Cr₹30 Cr₹31 Cr
₹22 Cr₹22 Cr₹12 Cr₹17 Cr₹13 Cr₹8 Cr₹19 Cr₹22 Cr₹21 Cr₹20 Cr₹22 Cr₹23 Cr

Share Price Live Stats

Open (₹)415.00
Volume (₹)13,141.00
High (₹)415.00
Upper Circuit495.00
Low (₹)409.80
Lower Circuit330.00
Prev Close412.50
52W High (₹)467.80
Price410.40
52W Low (₹)268.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)4161.22 Cr
Div. Yield (%)0.02
PE Ratio56.65
Debt to Equity0.58
Price to Book4.14
Book Value66.31
EPS (TTM)7.33
Face Value1.00
ROE (%)10.14

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
LAURUSLABSNSE
CIPLANSE
DRREDDYNSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
GUFICBIONSE
LTP
1W Low
1W High
Market cap (₹)
1751.9-8.1 (-0.46%)
1743.10
1776.60
4,24,466Cr
9122-218 (-2.33%)
9060
9431.50
2,46,222Cr
4599-57.9 (-1.24%)
4551.80
4682
1,76,301Cr
1115.4-2.1 (-0.19%)
1107.30
1139.80
1,12,818Cr
2041.4+4.8 (0.24%)
2007.80
2069.20
1,10,823Cr
1316.5+15.5 (1.19%)
1300.20
1333.30
1,07,447Cr
1221+24 (2.01%)
1196.90
1250.70
1,03,471Cr
2336.7-31.8 (-1.34%)
2328.10
2426.80
97,850Cr
1669.9-23.1 (-1.36%)
1660.10
1715
96,836Cr
1935-21.5 (-1.10%)
1925.70
1964.90
89,629Cr
410.4+4.1 (1.01%)
399.50
423.70
4,161Cr

Key Highlights of Gufic Biosciences Ltd’s P&L

In 2026-03-31, Gufic Biosciences Ltd reported total revenue of ₹946.66Cr, compared with ₹823.43Cr in 2025-03-31, reflecting Gufic Biosciences Ltd turnover.

Depreciation was ₹30.83Cr and finance costs were ₹36.61Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹86.55Cr in 2026-03-31 as compared to ₹94.14Cr in 2025-03-31.

Net Profit (PAT) was ₹64.21Cr in 2026-03-31 compared with ₹69.65Cr in 2025-03-31.

Earnings per share (EPS) were ₹6.40 in 2026-03-31, compared with ₹6.95 in 2025-03-31.